How long does it take to see results from tesamorelin?
The dose-ranging trial gave daily injections for 12 weeks, and that is the timepoint its trunk fat result refers to.
GHRH analogUpdated
Short answer
The dose-ranging trial gave daily injections for 12 weeks, and that is the timepoint its trunk fat result refers to.[1]
What the trials timed
At the end of the dose-ranging course the high-dose group had 9.2% less trunk fat versus a 0.8% rise on placebo.[1]
The trial extension showed the visceral fat reduction held at about 18% by 12 months.[2]
Results did not last without the drug: visceral fat reaccumulated after discontinuation.[3]
The label tells prescribers to reconsider continuing in patients who have not had a reduction in visceral fat.[4]
More questions on Tesamorelin
More on Tesamorelin
Sources
- 1A placebo-controlled, dose-ranging study of a growth hormone releasing factor in HIV-infected patients with abdominal fat accumulation.AIDS (London, England) · 2005PMID 16052083Accessed 2 Oct 2026
- 2Effects of tesamorelin, a growth hormone-releasing factor, in HIV-infected patients with abdominal fat accumulation: a randomized placebo-controlled trial with a safety extension.Journal of acquired immune deficiency syndromes (1999) · 2010PMID 20101189Accessed 2 Oct 2026
- 3Long-term safety and effects of tesamorelin, a growth hormone-releasing factor analogue, in HIV patients with abdominal fat accumulation.AIDS (London, England) · 2008PMID 18690162Accessed 2 Oct 2026
- 4EGRIFTA SV prescribing information (FDA label)FDA label, DailyMed · current labeldailymed.nlm.nih.govAccessed 2 Oct 2026
Found an error? Report a correction.